首页 > 抗体蛋白 > 抗体
APC anti-mouse Ly-6C Antibody
产品名称:
APC anti-mouse Ly-6C Antibody
产品类别:
抗体
产品编号:
128015
产品应用:
128015
[价格]
规格 价格 库存
25µg ¥ 1392 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  2. Tebartz C, et al. 2015. J Immunol. 194:1100. PubMed
  3. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  4. MohanKumar K, et al. 2019. Nat Commun. 10:3494. PubMed
  5. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  6. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  7. Aggen DH, et al. 2020. Clin Cancer Res. . PubMed
  8. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  9. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  10. Rosenheinrich M, et al. 2015. PLoS One. 10: 0136290. PubMed
  11. Borggrewe M, et al. 2018. Glia. 66:2645. PubMed
  12. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  13. Jahan S, et al. 2022. J Biol Chem. :102386. PubMed
  14. Price P, et al. 2014. J Virol. 88:10840. PubMed
  15. Zas?ona Z, et al. 2014. J Immunol. 193:4245. PubMed
  16. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  17. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  18. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  19. Cheng G, et al. 2021. iScience. 24:102673. PubMed
  20. Pingili AK, et al. 2021. Cell Reports. 35(12):109285. PubMed
  21. Earnest JT, et al. 2021. Cell Reports. 35(1):108962. PubMed
  22. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  23. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  24. Zhang X, et al. 2022. J Neuroinflammation. 19:111. PubMed
  25. Ye M, et al. 2022. Nat Nanotechnol. 17:880. PubMed
  26. Getts D, et al. 2014. Sci Transl Med. 15:219. PubMed
  27. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  28. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  29. Godbersen-Palmer C, et al. 2020. J Immunol. 204:2973. PubMed
  30. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  31. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  32. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  33. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  34. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  35. Ray A, et al. 2014. J Immunol. 192:5109. PubMed
  36. Kienzl M, et al. 2020. Oncoimmunology. 9:1776059. PubMed
  37. Werneburg S, et al. 2020. Immunity. 52(1):167-182.e7.. PubMed
  38. Anderson MC, et al. 2018. Cell Chem Biol. 25:483. PubMed
  39. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  40. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  41. Parlet CP, et al. 2019. Cell Rep. 27:187. PubMed
  42. Green DP, et al. 2019. Neuron. 101:412. PubMed
  43. Zhang S, et al. 2019. Cell Metab. 29:443. PubMed
  44. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  45. Li Y, et al. 2021. Brain Behav Immun. 91:267. PubMed
  46. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  47. Ajina R, et al. 2021. Cancer Immunol Res. 9:386. PubMed
  48. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  49. Tanaka T, et al. 2015. J Immunol. 194:2004. PubMed
  50. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  51. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  52. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  53. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  54. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  55. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  56. Heng Y, et al. 2021. J Neuroinflammation. 18:57. PubMed
  57. Radjabova V, et al. 2015. J Immunol. 195: 3149 - 3159. PubMed
  58. Christ A, et al. 2018. Cell. 172:162. PubMed
  59. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  60. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  61. Liu H, et al. 2022. Front Pharmacol. 13:949316. PubMed
  62. Holokai L, et al. 2020. Cancers (Basel). 12:00. PubMed
  63. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  64. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  65. Deczkowska A, et al. 2017. Nat Commun. 8:717. PubMed
  66. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  67. Liu X, et al. 2021. Int J Nanomedicine. 16:5675. PubMed
  68. Kolodziejczyk AA, et al. 2020. Nat Med. 26:1899. PubMed
  69. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  70. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  71. Ritzel RM, et al. 2021. Glia. 69:746. PubMed
  72. Sauter K, et al. 2014. J Leukoc Biol. 96:265. PubMed
  73. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  74. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  75. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  76. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  77. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  78. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  79. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  80. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  81. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  82. Karki R, et al. 2020. bioRxiv. . PubMed
  83. Clemente C, et al. 2018. Nat Commun. 9:910. PubMed
  84. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  85. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  86. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  87. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  88. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  89. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  90. Karki R, et al. 2021. Cell. 184:149. PubMed
  91. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  92. Mukovozov I, et al. 2015. J Immunol. 195: 3334 - 3344. PubMed
  93. Molgora M, et al. 2020. Cell. 182:886. PubMed
  94. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  95. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  96. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  97. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  98. Schaftenaar FH, et al. 2019. Sci Rep. 9:17391. PubMed
  99. Kitamoto S, et al. 2020. Cell. 182(2):447-462.e14. PubMed
  100. Kratochvill F, et al. 2015. Cancer Res. 75: 3054-3064. PubMed
  101. Pisano F, et al. 2014. PLoS One. 9:103541. PubMed
  102. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  103. Hsia HC, et al. 2017. J Leukoc Biol. 101:1053. PubMed
  104. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  105. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  106. Collins C, et al. 2014. Proc Natl Acad Sci U S A. 111:9899. PubMed
  107. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  108. Hamdan F, et al. 2021. Journal for ImmunoTherapy of Cancer. 9(8):. PubMed
  109. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  110. Ghosh S, et al. 2019. Commun Biol. 0.325. PubMed
  111. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  112. Zhang X, et al. 2020. Glia. . PubMed
  113. Kim I et al. 2015. Brain and behavior. 5(12):e00403 . PubMed
RRID
AB_1732087 (BioLegend Cat. No. 128015) AB_1732076 (BioLegend Cat. No. 128016)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线